Patient Derived Xenografts Expand Human Primary Pancreatic Tumor Tissue Availability for ex vivo Irreversible Electroporation Testing

New methods of tumor ablation have shown exciting efficacy in pre-clinical models but often demonstrate limited success in the clinic. Due to a lack of quality or quantity in primary malignant tissue specimens, therapeutic development and optimization studies are typically conducted on healthy tissu...

Descripción completa

Detalles Bibliográficos
Autores principales: Brock, Rebecca M., Beitel-White, Natalie, Coutermarsh-Ott, Sheryl, Grider, Douglas J., Lorenzo, Melvin F., Ringel-Scaia, Veronica M., Manuchehrabadi, Navid, Martin, Robert C. G., Davalos, Rafael V., Allen, Irving C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257557/
https://www.ncbi.nlm.nih.gov/pubmed/32528898
http://dx.doi.org/10.3389/fonc.2020.00843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257557/
https://www.ncbi.nlm.nih.gov/pubmed/32528898
http://dx.doi.org/10.3389/fonc.2020.00843

Ejemplares similares